Suppr超能文献

美国国立卫生研究院卒中量表系列评分对急性缺血性卒中动脉状况的识别准确性。

Accuracy of serial National Institutes of Health Stroke Scale scores to identify artery status in acute ischemic stroke.

作者信息

Mikulik Robert, Ribo Marc, Hill Michael D, Grotta James C, Malkoff Marc, Molina Carlos, Rubiera Marta, Delgado-Mederos Raquel, Alvarez-Sabin Jose, Alexandrov Andrei V

机构信息

Department of Neurology, University of Texas Health Science Center at Houston, USA.

出版信息

Circulation. 2007 May 22;115(20):2660-5. doi: 10.1161/CIRCULATIONAHA.106.651026. Epub 2007 May 14.

Abstract

BACKGROUND

Early recovery after intravenous thrombolysis can be observed in stroke; however, the utility of measuring clinical improvement to assess artery status has not been established. We sought to determine the accuracy of serial National Institutes of Health Stroke Scale (NIHSS) scores to detect complete early recanalization of the middle cerebral artery.

METHODS AND RESULTS

Data from the CLOTBUST trial (Combined Lysis of Thrombus in Brain Ischemia Using Transcranial Ultrasound and Systemic tPA) were used to determine the most sensitive and specific NIHSS-derived parameter to identify complete recanalization. Then, reproducibility was tested against a separate patient population (Barcelona data set). NIHSS scores were determined before tissue plasminogen activator bolus and at 60 and 120 minutes in both data sets. Receiver operating characteristic curves were used to compare test performance. The accuracy of individual cutoffs was demonstrated by sensitivity, specificity, and positive and negative predictive values. A total of 122 patients in the CLOTBUST data set and 98 in the Barcelona data set received 0.9 mg/kg intravenous tissue plasminogen activator [mean age 69+/-12 versus 72+/-12 years, 57% male versus 51% male, median NIHSS 16 versus 17 points, mean time from onset to treatment 140+/-32 versus 177+/-59 minutes, and complete recanalization of the middle cerebral artery in 19% versus 17%). For identification of recanalization, an NIHSS score reduction of > or = 40% offered the best tradeoff, with sensitivity, specificity, positive predictive value, and negative predictive value of 65%, 85%, 50%, and 91% at 60 minutes and 74%, 80%, 58%, and 89% at 120 minutes, respectively. Test performance was equal in the Barcelona data set.

CONCLUSIONS

Relative changes in serial NIHSS scores can serve as a simple clinical indicator of arterial status after intravenous thrombolysis. Accuracy parameters are affected by the process of recanalization and its varying clinical significance.

摘要

背景

静脉溶栓后可观察到卒中患者的早期恢复情况;然而,测量临床改善程度以评估动脉状态的实用性尚未得到证实。我们试图确定美国国立卫生研究院卒中量表(NIHSS)系列评分检测大脑中动脉早期完全再通的准确性。

方法与结果

利用CLOTBUST试验(经颅超声和全身组织型纤溶酶原激活剂联合溶解脑缺血血栓)的数据来确定最敏感和特异的源自NIHSS的参数,以识别完全再通。然后,在另一组患者群体(巴塞罗那数据集)中测试其可重复性。在两个数据集中,均于静脉推注组织型纤溶酶原激活剂前以及60分钟和120分钟时测定NIHSS评分。采用受试者操作特征曲线比较检测性能。通过敏感性、特异性、阳性和阴性预测值来证明各个临界值的准确性。CLOTBUST数据集中共有122例患者,巴塞罗那数据集中有98例患者接受了0.9mg/kg静脉注射组织型纤溶酶原激活剂(平均年龄分别为69±12岁和72±12岁,男性分别占57%和51%,NIHSS中位数分别为16分和17分,从发病到治疗的平均时间分别为140±32分钟和177±59分钟,大脑中动脉完全再通的比例分别为19%和17%)。对于再通的识别,NIHSS评分降低≥40%提供了最佳的权衡,60分钟时的敏感性、特异性、阳性预测值和阴性预测值分别为65%、85%、50%和91%,120分钟时分别为74%、80%、58%和89%。巴塞罗那数据集中的检测性能相当。

结论

NIHSS系列评分的相对变化可作为静脉溶栓后动脉状态的一个简单临床指标。准确性参数受再通过程及其不同临床意义的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验